Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Assets: 2021-2025

Historic Assets for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $145,371.

  • ProQR Therapeutics N.V's Assets rose 23.88% to $145,371 in Q3 2025 from the same period last year, while for Sep 2025 it was $145,371, marking a year-over-year increase of 23.88%. This contributed to the annual value of $179.5 million for FY2024, which is 20.33% up from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Assets stood at $145,371 for Q3 2025, which was down 6.63% from $155,686 recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Assets peaked at $239.8 million during Q4 2021, and registered a low of $110,502 during Q1 2021.
  • Moreover, its 3-year median value for Assets was $159,559 (2025), whereas its average is $57.7 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Assets skyrocketed by 193,114.16% in 2022, and later tumbled by 99.92% in 2024.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Assets stood at $239.8 million in 2021, then declined by 27.10% to $174.8 million in 2022, then fell by 15.12% to $148.4 million in 2023, then crashed by 99.88% to $179,479 in 2024, then grew by 23.88% to $145,371 in 2025.
  • Its Assets stands at $145,371 for Q3 2025, versus $155,686 for Q2 2025 and $159,559 for Q1 2025.